本頁面由Tiger Trade Technology Pte. Ltd.提供服務

窺得兒醫藥

11.44
-0.3400-2.89%
成交量:86.54萬
成交額:1,004.40萬
市值:7.85億
市盈率:-0.74
高:11.88
開:11.71
低:11.40
收:11.78
52周最高:35.58
52周最低:9.92
股本:6,857.54萬
流通股本:6,116.90萬
量比:1.88
換手率:1.41%
股息:- -
股息率:- -
每股收益(TTM):-15.3950
每股收益(LYR):-16.6932
淨資產收益率:-45.91%
總資產收益率:0.38%
市淨率:0.44
市盈率(LYR):-0.69

資料載入中...

2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/21

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/21

重要事件披露

Form 8-K - Current report
2024/11/19

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/11/18

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/11/18

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/08

重要事件披露

Form 8-K - Current report
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/05

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/01

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/08/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/31

重要事件披露

Form 8-K - Current report
2024/07/30

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/24

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]